AtriCure, Inc. (ATRC) Stock Forecast
ATRC analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 4.10 / 5 from 10 analysts
- Price target
- $55.78 average of analyst targets
- Upside to target
- −0.5% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.01
- 52-week range
- $25.86 – $60.77
ATRC analyst ratings
10 analystsNumber of analysts at each rating.
ATRC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ATRC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.01 | −$0.03 | $0.05 | −$0.01 | +219.2% | 9 |
| Current fiscal year (2026) | $0.28 | $0.25 | $0.31 | −$0.11 | +358.4% | 9 |
| Next fiscal year (2027) | $0.43 | $0.21 | $0.64 | $0.28 | +52.7% | 9 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ATRC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $151.2M | $150.0M | $152.1M | +12.6% | 10 |
| Current fiscal year (2026) | $606.3M | $604.6M | $609.3M | +13.4% | 10 |
| Next fiscal year (2027) | $679.7M | $672.2M | $685.6M | +12.1% | 10 |
ATRC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ATRC revenue: reported and forecast
ATRC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.02 | $0.01 | $0.01 | $0.01 | $0.01 | −22.2% | 2 up · 5 down |
| Current fiscal year (2026) | $0.12 | $0.28 | $0.28 | $0.28 | $0.28 | +133.1% | 8 up · 0 down |
| Next fiscal year (2027) | $0.35 | $0.43 | $0.43 | $0.43 | $0.43 | +24.5% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ATRC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ATRC beat in 11 of 12.
What analysts expect from ATRC
10 analysts cover AtriCure; their consensus rating is buy (4.10 on a 1–5 scale, where 5 is a strong buy). The average price target is $55.78, 0.5% below the latest close of $56.07. Analysts expect earnings of $0.28 per share for 2026, +358.4% from a year earlier. For 2027 the average estimate is $0.43 per share on revenue of $679.7 million. AtriCure beat the EPS estimate in 11 of the last 12 quarters.
Related: ATRC income statement, ATRC key metrics, ATRC chart. See the ATRC stock overview for the latest quote and news.
ATRC forecast FAQ
What is AtriCure's price target?
The average analyst price target for AtriCure is $55.78, 0.5% below the latest close of $56.07.
Is AtriCure a buy, hold or sell?
Of 10 analysts covering AtriCure, 4 rate it a strong buy, 3 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is AtriCure's EPS forecast?
Analysts forecast $0.28 per share for 2026 (range $0.25 to $0.31); for 2027 the estimate is $0.43.
What is AtriCure's revenue forecast?
The average revenue estimate for 2026 is $606.3 million, growth of 13.4%; for 2027 it is $679.7 million.
When does AtriCure report earnings?
AtriCure is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $0.01.
Does AtriCure usually beat earnings estimates?
AtriCure reported EPS at or above the analyst estimate in 11 of the last 12 quarters.